Progression of undiagnosed cutaneous T-cell lymphoma during efalizumab therapy.
Hernandez
Claudia
C
Worobec
Sophie M
SM
Gaitonde
Sujata S
SS
Kiripolsky
Monika L
ML
Aquino
Kristen
K
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018450:Disease Progression; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000175:diagnosis / Q000473:pathology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab